Articles tagged with "PsA"

Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

July 19, 2022 • By Michele B. Kaufman, PharmD, BCGP

Spine School: Axial Manifestations of Psoriatic Arthritis

July 15, 2022 • By Jason Liebowitz, MD

European Medicines Agency Committee Issues Positive Opinion for Secukinumab in Pediatric Arthritic Disease

June 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

Medication Preferences & Current Practices for PsA

May 11, 2022 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Risankizumab-rzaa for PsA

April 20, 2022 • By Michele B. Kaufman, PharmD, BCGP

Pregnancy Outcomes in Patients with Psoriatic Arthritis

March 1, 2022 • By Arthritis & Rheumatology

New Data Highlight Effectiveness of Guselkumab for Patients with PsA

February 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA

February 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

Risk of IBD in Patients with Psoriasis, PsA & Ankylosing Spondylitis Starting IL-17 Inhibitors

February 2, 2022 • By Arthritis & Rheumatology

Risankizumab Effective Against Refractory Psoriatic Arthritis

January 22, 2022 • By Matthew Phelan